Nadège Vimond
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 4
- Immune responses and vaccinations 2
-
- Angiogenesis and VEGF in Cancer 3
- Co-authors
- Nathalie Jacques (5 shared papers)Philippe Vielh (2 shared papers)Fanny Billiot (2 shared papers)A. Laplanche (1 shared paper)Françoise Drusch (1 shared paper)Ludovic Lacroix (1 shared paper)David Planchard (1 shared paper)Jean‐Charles Soria (1 shared paper)
- Journals
- British Journal of Cancer (2 papers)Frontiers in Immunology (2 papers)Blood Advances (2 papers)Transplantation (2 papers)Clinical and Translational Medicine (1 paper)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
Nadège Vimond
14 papers receiving 692 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 265
- Oncology 439
- Hepatology 89
- Immunology 123
- Pulmonary and Respiratory Medicine 140
Countries citing papers authored by Nadège Vimond
This map shows the geographic impact of Nadège Vimond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Vimond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Vimond more than expected).
Fields of papers citing papers by Nadège Vimond
This network shows the impact of papers produced by Nadège Vimond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Vimond. The network helps show where Nadège Vimond may publish in the future.
Co-authors
The 25 scholars most cited alongside Nadège Vimond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 325 | |
| 2 | 2012 | 105 | |
| 3 | 2019 | 57 | |
| 4 | 2011 | 44 | |
| 5 | 2008 | 40 | |
| 6 | 2011 | 39 | |
| 7 | 2020 | 22 | |
| 8 | 2019 | 19 | |
| 9 | 2020 | 13 | |
| 10 | 2022 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2022 | 7 | |
| 13 | 2020 | 2 | |
| 14 | 2022 | 1 |
About Nadège Vimond
Nadège Vimond is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 14 papers that have together received 698 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (4 papers), Cancer Genomics and Diagnostics (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers), CAR-T cell therapy research (2 papers) and Immune responses and vaccinations (2 papers). The work is most often cited by research in Cancer Research (265 citations), Oncology (439 citations), Hepatology (89 citations), Immunology (123 citations) and Pulmonary and Respiratory Medicine (140 citations). Nadège Vimond has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Nathalie Jacques, Philippe Vielh, Fanny Billiot, A. Laplanche, Françoise Drusch, Ludovic Lacroix, David Planchard, Jean‐Charles Soria, Karim Fizazi and Fabrice André. Their work appears in journals such as British Journal of Cancer, Frontiers in Immunology, Blood Advances, Transplantation and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.